Sernova Corp T.SVA

'Disappointing Viacyte'

[wj]

https://endpts.com/disappointing-viacyte-data-raise-questions-about-future-of-companys-attempted-diabetes-cure/

[BioTeck]

'The results raise the question of whether ViaCyte might change trajectory and follow Vertex: fully differentiate their cells, and insert them without a device.' 'The concerns about tumors have also dwindled. I think the teratoma concern is behind us, said Jay Skyler, a professor at the University of Miamis Diabetes Research Institute and a scientific advisor to ViaCyte' Sernovas

[Mercuryfilling1]

Did you read the full article Bio or just cherry pick to be dismissive of it?  Anyone can cherry pick...look Ma, no hands: "Many of ViaCyte’s problems stem from its decision to use precursor cells, Tang said. It was unclear whether these cells would properly develop into islet cells if left exposed. And there were concerns that the cells could keep dividing and form teratomas, a type

[BioTeck]

Keep reading you dimwit. Vertex doesn't use a device because they don't use precursor cells. Neither does sernova. But I bet you knew that. Look mom, no brains! I get a blue ribbon for participating too!

[MoneyMouth]

Doesn't change the fact that your "analysis" on that article and its implications for Sernova is plain wrong

[BioTeck]

Obviously I have high hopes else I'd be long gone. I just don't trust blindly given the amount invested and I question everything that comes from management. Call me names but it is smart investing.

[MoneyMouth]

Call it cautious investing sure, but when the share price starts to speak for itself, making a strong and steady climb, completely remincent of this time last year, you can't help but get excited

[Redbaron2211]

Bio that article is incredibly bullish for SVA for so many reasons.  Maybe post the full paragraph; "The concerns about tumors have also dwindled. “I think the teratoma concern is behind us,” said Jay Skyler, a professor at the University of Miami’s Diabetes Research Institute and a scientific advisor to ViaCyte. Skyler, who praised ViaCyte’s results, noting its “technology is still in

[Redbaron2211]

Beat me to it Mercuryfilling1 agree was definitely misleading.  

[BioTeck]

Vertex is mentioned several times in the article but not a single mention of Sernova. Hey Spillup, you should hire another IR firm. Give them what you have left of the DSUs or better yet, let's do another placement so you can generate some cash to pay them. Do it at 1.00 so Canaccord and Leede can give you that analyst report you've been waiting for.

[Bassenon123]

I think Sernova is not mentionned because it is not US based. There are companies in the world in the same area...none mentionned. No need to always be so angry.

[Metalsguy1]

umm...if you are not angry when management lies to you, then there is something wrong with you.